JEFFREY SOSMAN will join the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as co-leader of the Translational Research in Solid Tumors Program and director of the Melanoma Program, effective May 1. He will also serve as director for faculty development at the Lurie Cancer Center.
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
